QIAGEN NV ORD
			Symbol			QGEN

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

QIAGEN and British Veterinary Laboratories Agency Expand Partnership in Veterinary Testing

2009-11-05 02:30 ET - News Release

New Agreement Covers Widespread Bacterial Infections in Horses

Company Website: http://www1.qiagen.com/about/Press/?WT.svl=m
VENLO, Netherlands -- (Business Wire)

QIAGEN (NASDAQ:QGEN) (FWB:QIA) today announced an expansion of its strategic partnership with the United Kingdom’s Veterinary Laboratories Agency (VLA), one of the world’s leading research institutions in veterinary science. Under the terms of the agreement, QIAGEN has received the exclusive rights to commercialize three new PCR-based tests for the detection of widespread bacterial diseases in horses. Financial details have not been disclosed.

The new tests developed with and validated by the VLA target three different common bacterial infections: Streptococcus equi, Klebsiella pneumoniae and Pseudomonas aeruginosa.

The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try, click here for a free 30 day trial subscription.